Cited by 186Extracellular vesicles in diseaseRNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications

Open access
Amiri, Ala, Bagherifar, Rafieh, Ansari Dezfouli, Ehsan, Kiaie, Seyed Hossein, Jafari, Reza, Ramezani, Reihaneh·2022·Journal of Translational Medicine

Abstract

Nanocarriers as drug/biomolecule delivery systems have been significantly developed during recent decades. Given the stability, reasonable delivery efficiency, and safety of nanocarriers, there are several barriers in the fulfillment of successful clinical application of these delivery systems. These challenges encouraged drug delivery researchers to establish innovative nanocarriers with longer circulation time, high stability, and high compatibility. Exosomes are extracellular nanometer-sized vesicles released through various cells. These vesicles serve as nanocarriers, possessing great potential to overcome some obstacles encountered in gene and drug delivery due to their natural affinity to recipient cells and the inherent capability to shuttle the genes, lipids, proteins, and RNAs between cells. So far, there has been a lot of valuable research on drug delivery by exosomes, but research on RNA delivery, especially mRNA, is very limited. Since mRNA-based vaccines and therapies have recently gained particular prominence in various diseases, it is essential to find a suitable delivery system due to the large size and destructive nature of these nucleic acids. That's why we're going to take a look at the unique features of exosomes and their isolation and loading methods, to embrace this idea that exosome-mediated mRNA-based therapies would be introduced as a very efficient strategy in disease treatment within the near future. Graphical Abstract

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12967-022-03325-7

Cites

151 of 151 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [52]Lundberg S, Karlsson E, Dahlberg H, Glansk M, Larsson S, Larsson S, et al. Exosomes and lipid nanoparticles - the future of targeted drug delivery [Student thesis]; 2020.
  2. [140]Hou X Zaks T Langer R Dong Y Lipid nanoparticles for mRNA delivery Nat Rev Mater 2021 89 1 17 PMC8353930 34394960

Cited by

Sorted by citations

Authors
Amiri, A., Bagherifar, R., Ansari Dezfouli, E., Kiaie, S. H., Jafari, R., & Ramezani, R.
Affiliations
  • Islamic Azad University, Tehran (IR)
  • Tabriz University of Medical Sciences (IR)
  • Urmia University (IR)
  • Alzahra University (IR)
Corresponding author
  • Jafari, Reza
  • Ramezani, Reihaneh
Venue
Journal of Translational Medicine
Published
2022-03-14
Volume
20
Issue
1
Pages
125-125
ISSN
1479-5876 (ISSN-L)
OpenAlex
W4220801009
Cited by
186
References
151
Citations by year
2026: 41 · 2025: 52 · 2024: 44 · 2023: 34 · 2022: 15
FWCI
3.77
Type
journal article
Language
en
Open access
Locations
  • Journal of Translational Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, cc-by)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
exosomes, RNA delivery, mRNA delivery, nanocarriers, extracellular vesicles, exosome isolation, mRNA vaccines, mRNA therapeutics, gene delivery, drug delivery
MeSH terms
Extracellular Vesicles, RNA, Drug Delivery Systems, Exosomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review